Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SMC (Chengdu) Biotechnology is a specialized biotechnology company focused on the research, development, and manufacturing of high-quality peptides and related chemical reagents. Based in Chengdu, China, the company offers a comprehensive range of services including custom peptide synthesis, large-scale peptide production, and the supply of amino acid derivatives and pharmaceutical intermediates. SMC serves a global clientele across the pharmaceutical, biotechnology, and academic sectors, supporting drug discovery and life science research. The company emphasizes rigorous quality control and technical expertise in handling complex peptide modifications and difficult sequences. Their facilities are designed to support both research-grade and pilot-scale production requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 舒美奇成都生物科技.